Skip to main content
. Author manuscript; available in PMC: 2020 Aug 14.
Published in final edited form as: Leukemia. 2020 Feb 14;34(7):1741–1750. doi: 10.1038/s41375-020-0741-0

Table 3.

Multivariable analysis for event-free survival from EOI and EOC

Characteristic1 n (%) Event-free Survival from EOI Event-free Survival from EOC
HR 95% CI p-value HR 95% CI p-value
Age at diagnosis <10 years 39 (49) 1 -- 0.278 1 -- 0.346
≥10 years 41 (51) 1.69 0.65, 4.38   1.59 0.60, 4.22
Initial WBC (/uL) <50,000 57 (71) 1 -- 0.419 1 -- 0.384
≥50,000 23 (29) 0.65 0.23, 1.87   0.61 0.19, 1.91
Cytogenetic classification2 Neutral 59 (74) 1 -- 0.092 1 -- 0.099
Favorable 15 (19) 0.18 0.02, 1.47 0.19 0.02, 1.48
Adverse 6 (7) 2.18 0.42, 11.22 2.12 0.41, 10.90
EOI MRD3 Negative 57 (71) 1 -- <0.001 -- -- --
Positive 23 (29) 6.00 2.20, 16.37   -- -- --
EOI/EOC MRD3 Neg/Neg 57 (71) -- -- -- 1 -- 0.004
Pos/Neg 13 (16) -- -- -- 6.54 1.92, 22.25
Pos/Pos 3 (4) -- -- -- 9.01 1.51, 53.86
Pos/Unk. 7 (9) -- -- -- 5.06 1.45, 17.70
1

All candidate predictors in Table 1 tested in stepwise multivariable model with endpoint of OS, see methods. Age, WBC, cytogenetics included as a priori “base” model irrespective of significance.

2

As per AALL08B1 criteria; excludes two patients with unknown cytogenetics.

3

MRD considered positive ≥0.01% at either time-point. HR = hazard ratio, EOI = end of induction, EOC = end of consolidation WBC = white blood cell count